Cell and Gene Therapy Supply Chain/Logistics Market Dynamics Shaped by Temperature-Controlled Solutions and Software Integration

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the “Global Cell and Gene Therapy Supply Chain/Logistics Market – (By Application Area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification and treatment follow-up), By Type of Software Solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system), By End-User (Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization), By Type of Deployment (Cloud-Based, On-premises)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034.”

The Cell and Gene Therapy Supply Chain/Logistics Market Size is valued at 1.5 billion in 2024 and is predicted to reach 4.4 billion by the year 2034 at an 11.9 % CAGR during the forecast period for 2025-2034.

 Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1694

The Global Cell and Gene Therapy Cold Chain Logistics market delivers specialized services that support the end-to-end therapeutic supply chain, including patient identification, cell collection, therapy administration, and long-term outcome monitoring. With the rapid expansion of personalized medicine and the increasing deployment of patient-specific cell and gene therapies, there is a growing demand for flexible, scalable, and reliable logistics solutions that ensure product integrity throughout the supply process.

Market growth is largely driven by advancements in biotechnology and the widespread adoption of individualized treatments for complex conditions such as cancer, genetic disorders, and autoimmune diseases. These developments highlight the necessity of robust cold chain logistics systems capable of maintaining the stability, efficacy, and safety of temperature-sensitive therapies during storage, transportation, and handling.

However, the market faces challenges stemming from the inherent complexity and fragmentation of the supply chain. The distribution network spans multiple stakeholders—including pharmaceutical manufacturers, contract manufacturing organizations (CMOs), research institutions, healthcare providers, and regulatory authorities—each with distinct responsibilities within the therapeutic lifecycle. Effective coordination, stringent quality control measures, and compliance with regulatory standards are critical for managing these complexities successfully.

Moreover, ongoing innovations in cell and gene therapy development are producing increasingly sophisticated and high-value treatments, further emphasizing the need for adaptable and dependable cold chain logistics solutions to facilitate the timely and secure delivery of temperature-sensitive therapeutics while preserving clinical efficacy.

List of Major Players in the Cell and Gene Therapy Supply Chain/Logistics Market:

• Be The Match BioTherapies
• MAK-SYSTEM
• Cryoport
• Brooks Life Sciences
• Lykan Bioscience
• Clarkston Consulting
• SAP
• Hypertrust Patient Data Care
• Haemonetics
• MasterControl
• TraceLink
• SAVSU Technologies
• TrakCel
• Title21 Health Solutions
• sedApta Group
• Vineti
• Stafa Cellular Therapy
• Thermo Fisher Scientific
• McKesson
• Biocair
• Marken
• Modality Solutions
• Almac
• Arvato Supply Chain Solutions SE
• Catalent, Inc
• BioLife Solutions, Inc
• Biostor Ltd
• Yourway Biopharma Services Company
• Atelerix Ltd
• Other Prominent Players

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

Market Dynamics

Drivers:

The global cell and gene therapy cold chain logistics market is experiencing robust growth, driven primarily by the rising adoption of personalized therapies for rare and complex diseases. These patient-specific treatments require sophisticated logistical solutions to ensure secure, timely, and reliable delivery. Technological advancements in gene editing platforms, including CRISPR, have accelerated the development, manufacturing, and distribution of cell and gene therapies.

Additionally, expedited regulatory pathways and supportive frameworks established by agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have facilitated faster approvals and commercialization. The growing focus on quality assurance, regulatory compliance, and patient advocacy for access to advanced therapeutics further underpins market expansion.

Challenges:

A key challenge in the cold chain logistics sector is maintaining strict temperature-controlled conditions throughout the supply chain. Cell and gene therapies require storage and transport within precisely regulated parameters to preserve safety and therapeutic efficacy. Managing these conditions is particularly complex during long-distance shipments or in regions with fluctuating environmental conditions, as even minor deviations can compromise product integrity.

To mitigate these risks, logistics providers are increasingly deploying advanced solutions such as real-time temperature monitoring systems, GPS-enabled tracking, and data logging technologies. Comprehensive contingency plans and rapid-response protocols are also critical to prevent product loss and ensure the reliability of temperature-sensitive therapeutic deliveries.

Regional Trends:

North America is expected to maintain a leading position in the global market, supported by a mature healthcare infrastructure, significant research and development investment, and strong demand for innovative therapies. The presence of major biopharmaceutical companies and advanced technological capabilities further consolidates the region’s market leadership.

Europe is also exhibiting considerable growth, driven by robust government support for therapeutic innovation, increased funding for cell and gene therapy research, and strategic collaborations between academic institutions and industry stakeholders. The region’s well-structured regulatory framework facilitates the efficient development and commercialization of novel therapies, reinforcing Europe’s position as a key contributor to the global market.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1694

Recent Developments:

• In Oct 2024, McKesson Corporation announced the introduction of InspiroGeneTM by McKesson (“InspiroGene”), a specialized entity exclusively aimed at facilitating the commercialization of cell and gene therapies (CGTs). InspiroGene offers a scalable and adaptable array of services, supported by a seasoned leadership team, to assist manufacturers, payers, and providers in maneuvering through the intricate environment of CGT commercialization, thereby ensuring patient access to essential, transformative medicines.
• In June 2024, Cryoport, Inc. formed a strategic collaboration to provide biotechnology and pharmaceutical companies with fully integrated manufacturing and shipping services for regenerative medicine products to advance cell and gene treatments.

Segmentation of Cell and Gene Therapy Supply Chain/Logistics Market-

By Application Area-

• Donor eligibility assessment
• Sample collection
• Manufacturing
• Logistics
• Patient verification and treatment follow-up

By Type of Software Solution-

• Cell orchestration platform
• Enterprise manufacturing system
• Inventory management system
• Laboratory information management system
• Logistics management system
• Patient management system
• Quality management system
• Tracking and tracing system

By End-User-

• Biobank
• Cell Therapy Lab
• Hospital
• Research Institute
• Commercial Organization

By Type of Deployment-

• Cloud-Based
• On-premises

By Region-

North America-

• The US
• Canada
• Mexico

Europe-

• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe

Asia-Pacific-

• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific

Latin America-

• Brazil
• Argentina
• Rest of Latin America

 Middle East & Africa-

• GCC Countries
• South Africa
• Rest of Middle East and Africa

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Tags: Cell and Gene Therapy Supply Chain/Logistics market